Detection of superoxide anion using an isotopically labeled nitrone spin trap: potential biological applications  by Zhang, Hao et al.
Detection of superoxide anion using an isotopically labeled nitrone spin
trap: potential biological applications
Hao Zhanga, Joy Josepha, Jeannette Vasquez-Vivarb, Hakim Karouic, Cline Nsanzumuhirec,
Pavel Marta¤sekd, Paul Tordoc, B. Kalyanaramana;*
aBiophysics Research Institute, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
bDepartment of Pathology and Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, WI, USA
cLaboratoire ‘Structure et Re¤activite¤ des Espe'ces Paramagne¤tiques’, Universite¤ de Provence, Marseille, France
dUniversity of Texas Health Sciences Center, San Antonio, TX, USA
Received 30 March 2000
Edited by Barry Halliwell
Abstract We describe the synthesis and biological applications
of a novel nitrogen-15-labeled nitrone spin trap, 5-ethoxycarbo-
nyl-5-methyl-1-pyrroline N-oxide ([15N]EMPO) for detecting
superoxide anion. Superoxide anion generated in xanthine/
xanthine oxidase (100 nM min31) and NADPH/calcium-
calmodulin/nitric oxide synthase systems was readily detected
using EMPO, a nitrone analog of 5,5P-dimethyl-1-pyrroline N-
oxide (DMPO). Unlike DMPO-superoxide adduct (DMPO^
OOH), the superoxide adduct of EMPO (EMPO^OOH) does
not spontaneously decay to the corresponding hydroxyl adduct,
making spectral interpretation less confounding. Although the
superoxide adduct of 5-(diethoxyphosphoryl)-5-methyl-pyrroline
N-oxide is more persistent than EMPO^OOH, the electron spin
resonance spectra of [14N]EMPO^OOH and [15N]EMPO^
OOH are less complex and easier to interpret. Potential uses
of [15N]EMPO in elucidating the mechanism of superoxide
formation from nitric oxide synthases, and in ischemia/reperfu-
sion injury are discussed.
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1. Introduction
There is a surge of research interest in the development of
more e¡ective and selective probes to detect superoxide anion
generated in enzymatic and cellular systems and perfused or-
gans [1^3]. Current assays for superoxide rely on the measure-
ment of cytochrome c reduction, chemiluminescence from lu-
cigenin and related dyes, nitro blue tetrazolium reduction to
formazan, dihydroethidium oxidation to ethidium, aconitase
inactivation/activation, or electron spin resonance (ESR) spin-
trapping. However, nearly all of these assays have been
criticized for various reasons [4^9]. We have undertaken this
study to improve the existing spin-trapping methodology for
detecting superoxide anion in biological systems.
5,5-Dimethyl-pyrroline N-oxide (DMPO) has been used for
decades to trap superoxide anion in biological systems [10]. A
major disadvantage of DMPO is that the DMPO-superoxide
adduct (DMPO^OOH) spontaneously decays to the DMPO^
hydroxyl adduct (DMPO^OH) and as a result, superoxide
anion was typically detected by monitoring the superoxide
dismutase-inhibitable formation of DMPO^OH. This poten-
tial drawback was recently overcome with the synthesis of a
phosphorylated analog, 5-(dimethoxyphosphoryl)-5P-methyl-
1-pyrroline N-oxide (DEPMPO) [11]. In contrast to DMPO^
OOH, the DEPMPO-superoxide adduct (DEPMPO^OOH)
does not decompose to the DEPMPO^hydroxyl adduct
(DEPMPO^OH) [10,11]. Despite the stability of DEPMPO^
OOH, the use of DEPMPO in superoxide spin-trapping re-
mains limited in biological systems because the ESR spectra
of DEPMPO adducts are complicated by an additional 31P
hyper¢ne coupling and the existence of diastereomers. Substi-
tution of the 5-methyl group with an electron-withdrawing
L-ethoxyphosphoryl group increased the stability of DEPM-
PO^OOH and led to the synthesis of a carboxylated analog,
5-ethoxycarbonyl-5-methyl-pyrroline N-oxide (EMPO) [12,
13]. The EMPO superoxide adduct (EMPO^OOH) was re-
ported to be eight times more stable than DMPO^OOH. In
addition, EMPO^OOH exhibits an ESR spectrum that is very
similar to that of DMPO^OOH. In this work, we show that
the signal-to-noise ratio of the ESR spectrum of EMPO^OOH
is further enhanced by labeling the nitrone group in EMPO
with a nitrogen-15 atom. We also discuss the use of
[15N]EMPO in the elucidation of the mechanism of superoxide
generation from endothelial and neuronal nitric oxide syn-
thases (eNOS and nNOS) and its implications in vascular
dysfunction.
2. Materials and methods
2.1. Materials
All chemicals were purchased from Sigma-Aldrich and used as re-
ceived.
2.2. Methods
2.2.1. Synthesis of [15N]EMPO. [15N]EMPO was synthesized
from the precursor compound, [15N]nitro ethyl propionate, which
was prepared as follows [14,15]. Ethyl 2-bromopropionate (5.85 g,
0.03 mol) was added while stirring to a mixture of 60 ml anhydrous
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dimethylformamide containing [15N]sodium nitrite (3.6 g, 0.05 mol)
and phloroglucinol dihydrate (4.0 g, 0.052 mol). The reaction was
continued at 25‡C for 2.5 h. The deep brown reaction mixture was
subsequently poured into 120 ml ice-cold water and extracted with
ether (4U50 ml). The combined ether extract was washed with 50 ml
saturated sodium bicarbonate solution, dried, and the ether removed
in a rotary evaporator. The residual yellow liquid was distilled (boil-
ing point 80‡C at 10 mm Hg pressure) to give a net yield of 3.2 g
(41%) [15N]2-nitro ethyl propionate, which was used in the synthesis
of [15N]2-ethoxycarbonyl-2-nitro pentanal.
Ethyl 2-nitropropionate (3.2 g) was added to a sodium ethoxide
solution (prepared by reacting 0.1 g metallic sodium in 20 ml dry
ethanol), followed by the addition of 1.5 ml acrolein. The mixture
was re£uxed at 40^50‡C for 3 h, acidi¢ed with 0.2 ml acetic acid,
and extracted with 50 ml dry ether. The ether extract containing the
product was passed through a silica gel column and eluted with a 3:1
mixture of hexane:ethyl acetate. Removal of the solvent yielded 3.1 g
(70%) [15N]2-ethoxycarbonyl-2-nitro pentanal. This aldehyde product
was converted to a 1:3 dioxolan derivative by re£uxing in 25 ml
benzene containing ethylene glycol (3 g) and p-toluene sulfonic acid
(50 mg) with the concomitant removal of water. The benzene solution
of 1:3 dioxolan was diluted with 50 ml ether and washed with H2O
(40 ml) and saturated sodium bicarbonate (40 ml). The solvent was
removed in a rotary evaporator and the pure dioxolan derivative (3 g,
80% yield) was isolated by distillation (boiling point 121^125‡C at
0.5 mm Hg pressure).
The dioxolan derivative was reduced with zinc dust (4 g) in 50%
aqueous ethanol (25 ml) containing ammonium chloride (0.6 g) at 5^
10‡C. After stirring for 2.5 h, the mixture was ¢ltered and the ¢ltrate
was concentrated and extracted with 4U25 ml chloroform. The
chloroform extract was dried and evaporated to yield a viscous oil
of the hydroxylamine. This hydroxylamine product was treated with
50 ml 0.3 N HCl and kept at room temperature for complete hydro-
lysis and liberation of the aldehyde. To this acid solution 10 ml con-
centrated ammonia solution was added and extracted with 4U25 ml
chloroform after saturating with sodium borate. The chloroform ex-
tract was dried and the solvent removed to obtain a yellow oil. Dis-
tillation of the yellow oil at 120‡C and 0.3 mm Hg pressure yielded 1.1
g (52%) [15N]EMPO, which was obtained as a colorless oil. The [14N]
analog of EMPO was prepared in a similar manner, starting from
commercially available [14N]2-nitro-ethyl propionate.
2.2.2. nNOS activity. nNOS activity was determined by quantify-
ing the conversion of L-[14C]arginine to L-[14C]citrulline as described
previously [16]. Brie£y, nNOS (66.7 nM) was added to reaction
mixtures (¢nal volume, 0.20 ml) containing HEPES (50 mM, pH
7.4), diethylenetriamine penta-acetic acid (DTPA) (100 WM), L-
[14C]arginine (0.1 mM, 0.625 WCi), NADPH (0.3^0.5 mM), calcium
chloride (0.2 mM), calmodulin (20 Wg ml31), tetrahydrobiopterin
(BH4) (10 WM), reduced glutathione (100 WM), and bovine serum
albumin (200 Wg ml31). To stop the reaction, an aliquot of the reac-
tion mixture (50 Wl) was diluted in HEPES (50 mM, pH 5.5) contain-
ing EGTA (0.5 mM) and chilled on ice. L-[14C]Citrulline was isolated
from the excess of L-[14C]arginine using a Dowex 50W-cation ex-
change column, and its concentration was determined by liquid scin-
tillation counting.
2.2.3. Xanthine oxidase activity. Xanthine oxidase was incubated
with xanthine (1 mM) in phosphate bu¡er (100 mM) containing
DTPA (100 WM). Formation of uric acid was monitored at 296 nm
using the extinction coe⁄cient of 11 000 M31 cm31. Because of inter-
ference with uric acid absorption, EMPO was excluded in optical
measurements.
2.2.4. ESR measurements. ESR spectra were recorded at room
temperature on a Varian E-109 spectrometer operating at 9.03 GHz
and 100 kHz ¢eld modulation equipped with a TE102 cavity or a loop-
gap resonator [17,18]. Typical spectrometer parameters were: micro-
wave power, 2 mW; modulation amplitude, 1 G; time constant, 0.064
s; scan rate, 1.67 G s31 ; number of scans, three unless otherwise
speci¢ed. nNOS was added to incubation mixtures (20 Wl, ¢nal vol-
ume) containing [14N]EMPO or [15N]EMPO, and the sample was
examined after incubation for 1 min. Data were collected using the
VIKING software program developed at the Medical College of Wis-
consin, and simulated with the ESR software developed by Rocken-
bauer [19] and Duling from the Laboratory of Molecular Biophysics
at the National Institute of Environmental Health Sciences, Research
Triangle Park, NC, USA.
3. Results
3.1. Trapping of superoxide anion by [14N]EMPO and
[15N]EMPO
Fig. 1A shows the ESR spectrum, characteristic of
[14N]EMPO^OOH, generated from the addition of xanthine
oxidase to aerobic incubations containing xanthine (1 mM),
[14N]EMPO (25 mM), and DTPA (100 WM) in phosphate
bu¡er (100 mM, pH 7.4). The ESR signal growth of
[14N]EMPO^OOH as a function of time is shown in Fig.
1B. The steady-state ESR spectrum was maintained for up
to 20 min under these experimental conditions. In the pres-
ence of Fe^EDTA, addition of xanthine oxidase to incuba-
tions containing xanthine (1 mM) and [14N]EMPO (25 mM)
produced the EMPO^OH adduct with a distinctly di¡erent
ESR spectrum (Fig. 1C).
Fig. 2A^C shows the ESR spectra of [14N]EMPO^OOH,
[15N]EMPO^OOH, and [14N]EMPO^OH generated in the
xanthine/xanthine oxidase system. Based on computer simu-
lations (dotted-line spectra), these spectra were assigned to a
mixture of two diastereomers. In the case of superoxide ad-
ducts, spectra 2A and 2B were simulated assuming the pres-
ence of two conformers undergoing a chemical exchange [19]
(Table 1).
To determine whether [14N]EMPO^OOH decays to form
Fig. 1. Trapping of superoxide and hydroxyl radical by [14N]EMPO,
formed in the xanthine/xanthine system. A: Incubation mixtures
contained xanthine (1 mM), [14N]EMPO (25 mM), DTPA (100 WM),
and xanthine oxidase (0.05 U ml31) in phosphate bu¡er (100 mM,
pH 7.4). The reaction was initiated by the addition of xanthine oxi-
dase, and the steady-state ESR spectrum was recorded after 15 min.
B: Time-dependent increase in the formation of EMPO^OOH. The
low-¢eld line was monitored as a function of time. Incubation con-
ditions were identical to those described above. C: Incubation con-
ditions are the same as (A) except the mixture contained Fe(III)^
EDTA (100 WM) instead of DTPA.
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other free radical adducts, we monitored the ESR spectra
(Fig. 3B) at di¡erent time points in xanthine/xanthine oxidase
incubations as indicated in Fig. 3A. In these spectra, no addi-
tional ESR signal was detected with decreasing signal intensity
from decaying [14N]EMPO^OOH. This pattern is clearly dif-
ferent from that of DMPO^OOH, which decayed to form
DMPO^OH. These results suggest that if the EMPO^OH
spectrum is detected, it is more likely to be formed from
trapping of hydroxyl radicals or by another mechanism than
from the decomposition of EMPO^OOH.
Next we evaluated the sensitivity of trapping superoxide by
[14N]EMPO and [15N]EMPO. Fig. 4A shows the rates of uric
acid formation (9.27 þ 0.07; 0.84 þ 0.07, and 0.11 þ 0.01 WM
min31) from three di¡erent xanthine oxidase concentrations.
The same incubations containing [14N]EMPO and
[15N]EMPO were used for ESR measurements. At the indi-
cated time points, the ESR spectra of [14N]EMPO^OOH (Fig.
4B) and [15N]EMPO (Fig. 4C) were recorded. The steady-state
EMPO^OOH spectrum can be easily detected at rates of
superoxide anion formation (w100 nM min31). A comparison
of Fig. 4B and C shows that under a wide range of superoxide
anion generation rates, the signal-to-noise ratio of
[15N]EMPO^OOH was signi¢cantly higher than that of
[14N]EMPO^OOH.
3.2. EMPO spin-trapping of superoxide anion generated by
nitric oxide synthase
Fig. 5 shows the ESR spectra of [14N]EMPO^OOH and
[15N]EMPO^OOH formed from the addition of BH4-free
nNOS to incubations containing NADPH (100 WM), Ca2
(0.2 mM)/calmodulin (20 Wg ml31), and EMPO (50 mM).
EMPO (50 mM) did not a¡ect the NOS activity as measured
by formation of L-citrulline (213 þ 15 nmol min31 (mg
protein)31). The signal-to-noise ratio of the superoxide adduct
obtained with the [15N]EMPO trap is signi¢cantly higher than
that obtained with [14N]EMPO (Fig. 5A,B). In the absence of
Fig. 2. Computer simulations of [14N]EMPO^OOH, [15N]EMPO^
OOH, and [14N]EMPO^OH. ESR spectra of these adducts were ob-
tained in xanthine/xanthine oxidase systems. Dotted lines indicate
the computer simulations using the parameters shown in Table 1.
Table 1
ESR hyper¢ne coupling constants for superoxide and hydroxyl spin adducts of EMPO
Spin adduct Diastereomers (%) Hyper¢ne coupling constant (G) Exchange rate (ns)
aN a
L
H a
Q
H
[14N]EMPO^OH 52 13.5 14.8 0.8 ^
48 13.5 12.4 ^
[14N]EMPO^OOH 54 12.8 12.1 0.15 130
46 12.8 8.6 ^
[15N]EMPO^OOH 55 17.9 12.0 0.3 140
45 17.8 8.7 ^
Fig. 3. Time-dependent changes in ESR spectra of EMPO^OOH.
A: The low-¢eld line of EMPO^OOH was monitored as a function
of time. Incubation conditions are the same as described in Fig. 1
except for xanthine oxidase (0.1 U ml31). B: At various time points
(marked by downward arrows), two steady-state ESR spectra were
observed. Spectra 1^5 were recorded at 5, 12, 20, 40, and 60 min
after starting the incubation. Note that EMPO^OOH does not de-
cay to EMPO^OH.
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Ca2/calmodulin, no ESR spectrum was obtained, indicating
that NOS activation was required to produce superoxide
anions (Fig. 5C). Real-time measurements of superoxide re-
leased from eNOS and inducible NOS were made possible
using [15N]EMPO (data not shown).
4. Discussion
4.1. Resolution enhancement caused by 15N-labeling
The ESR spectrum of [15N]EMPO^OOH consists of four
lines, compared to six lines detected for [14N]EMPO^OOH.
The four-line pattern arises from the interaction of an un-
paired electron with a 15N atom (I = 1/2) and a L-hydrogen
(I = 1/2). The ratio of hyper¢ne coupling between 14N and 15N
was calculated to be equal to the gyromagnetic ratio of 14N
and 15N magnetic moments (i.e. 0.7).
Although [15N]-substituted DMPO improved the signal-to-
noise ratio of DMPO^OOH and DMPO^OH, the
[15N]DMPO^OOH also decays to [15N]DMPO^OH. Thus
[15N]-substitution of DMPO did not remove this artifact. In
contrast, [15N]-substitution in EMPO has the added advan-
tage of increased stability of the [15N]EMPO^OOH adduct (as
compared to the [15N]DMPO^OOH), coupled with increased
spectral resolution. These features make [15N]EMPO an ideal
spin trap for detecting superoxide in biological systems.
4.2. Relative stability of cyclic nitrone superoxide adducts
Fig. 6 shows the relative half-lives of di¡erent superoxide
adducts of DMPO, DEPMPO, EMPO, and analogs. Substi-
tution of one of the methyl groups (at the C-5 position) in
DMPO with a strong electron-withdrawing diethoxyphos-
Fig. 4. Spin-trapping of superoxide anion produced at di¡erent rates
in the xanthine/xanthine oxidase system: e¡ect of [15N]-substitution
on spectral resolution. A: Incubation mixtures contained xanthine
(1 mM), DTPA (100 WM), and xanthine oxidase (0.5, 0.005, or
0.0005 U ml31) for optical measurements. For ESR measurements,
incubation mixtures were identical except [14N]EMPO or
[15N]EMPO (25 mM) was included. Formation of uric acid was
measured as shown in these traces. B: At di¡erent time points (1, 2,
and 3) indicated by a downward arrow, the incubation mixture was
transferred to an ESR capillary and the steady-state ESR spectra
were recorded. Traces 1, 2, and 3 indicate the EMPO^OOH spec-
trum detected in the incubation mixtures. C: Same as (B) except
that the incubation mixtures contain [15N]EMPO instead of
[14N]EMPO.
Fig. 5. Trapping of superoxide anion by [14N]EMPO and
[15N]EMPO, formed from neuronal nitric oxide synthase. A: Incu-
bations contained NADPH (0.5 mM), [14N]EMPO (25 mM), calci-
um (0.2 mM), calmodulin (20 Wg ml31), DTPA (100 WM), and puri-
¢ed nNOS (1 WM) in HEPES bu¡er (50 mM, pH 7.4). B: Same as
(A) but in the presence of [15N]EMPO (25 mM). C: Same as (A)
but containing superoxide dismutase (10 Wg ml31). D: Same as (A)
but in the absence of Ca2/calmodulin. ESR spectra were obtained
after 1 min following the addition of nNOS.
Fig. 6. Relative half-lives of di¡erent superoxide spin adducts. (Tak-
en from [12,20^22]).
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phoryl group resulted in the greatest stabilization of the cor-
responding superoxide adduct [20,21]. For example, the half-
life of DEPMPO^OOH is 14 times longer than that of
DMPO^OOH. When a methylene spacer was inserted be-
tween the phosphoryl group and the C-5 atom, the half-life
of the resulting superoxide adduct was diminished almost ¢ve
times [20]. EMPO^OOH, which has an electron-withdrawing
carboxyethyl group, has a half-life of 8 min. In addition to the
electron-withdrawing e¡ect, it appears that the relative size of
the substituent also plays a key role in the stabilization of the
superoxide adduct [22].
4.3. Potential biological applications
Increasing evidence suggests that enhanced generation of
superoxide anion plays a key role in endothelial dysfunction
and associated vascular pathologies [23,24]. It has been pro-
posed that eNOS can regulate both nitric oxide and super-
oxide anion formation in the vasculature [25,26]. BH4, a crit-
ical cofactor of all NOS enzymes, regulates nitric oxide and
superoxide anion formation from NOS [27]. In the absence of
BH4 or under limited availability of BH4, NOS enzyme be-
comes ‘uncoupled’, leading to superoxide formation at the
oxygenase domain [28]. ESR spin-trapping provided the ¢rst
evidence for formation of superoxide anion from puri¢ed
eNOS and nNOS under conditions of BH4 de¢ciency
[16,17]. As NOS £avin semiquinone can directly reduce cyto-
chrome c (acetylated and succinylated) and BH4 itself can
reduce cytochrome c by a mechanism independent of super-
oxide dismutase, superoxide formation from NOS cannot be
reliably measured by cytochrome c reduction [6,16,17]. Spin-
trapping is ideally suited for detecting superoxide formed in
these systems. Spin-trapping with [15N]EMPO should help
unravel the role of arginine, NOS inhibitors, and BH4 in
regulating superoxide formation from NOS.
[15N]EMPO may be useful in the detection of superoxide
during ischemia/reperfusion. DEPMPO spin-trapping pro-
vided the ¢rst spectroscopic evidence for superoxide forma-
tion in ischemia/reperfusion of isolated rat myocardium [3,11].
Because of the availability of pure [15N]EMPO, increased
stability of [15N]EMPO^OOH, and improved signal-to-noise
ratio, EMPO spin-trapping of superoxide is likely to have a
much broader application in cardiovascular and neurodegen-
erative pathologies.
In summary, we conclude that the increased stability of
15N-labeled EMPO superoxide adduct coupled with its en-
hanced spectral resolution should make this nitrone trap ideal
for detecting and quantitating superoxide anion formed from
NOS enzymes and other oxidases in vascular and neuronal
tissues.
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